Targeted Drugs for Parkinson's Disease Market Expansion Opportunities at 7.2% CAGR Outlook for 2026–2034
 According to a new report from Intel Market Research, the global Targeted Drugs for Parkinson's Disease market was valued at USD 4.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2025–2034). This growth is fueled by increasing global prevalence of Parkinson's...
0 Comments 0 Shares 53 Views